Mental health medications
ADHD Medications
Learn how stimulant and non-stimulant ADHD medications work, common and serious side effects, important warnings and questions to discuss with a prescriber.
Featured provider · Affiliate link
BetterHelp
Talk to a licensed therapist from home — by message, chat, phone or video.
- 30,000+ licensed therapists
- From $70–$100/week
- 125+ insurance plans
Featured provider · Affiliate link
Sesame
Book online therapy or psychiatry at an upfront cash price — no insurance needed.
- Visits from about $34
- Same-day appointments
- Therapy, psychiatry & refills
At a glance
- Medication class
- ADHD medications (stimulants and non-stimulants)
- Examples (generic name, brand name)
- methylphenidate (Ritalin, Concerta)
- dexmethylphenidate (Focalin)
- mixed amphetamine salts (Adderall)
- lisdexamfetamine (Vyvanse)
- atomoxetine (Strattera)
- viloxazine (Qelbree)
- guanfacine extended-release (Intuniv)
Examples are for education only and are not a complete list or a recommendation.
Boxed warning: Prescription stimulants carry an FDA boxed warning about their high potential for misuse and abuse, which can lead to addiction, overdose and death. Atomoxetine and viloxazine carry a boxed warning about an increased risk of suicidal thoughts in children and adolescents.
What are ADHD medications?
ADHD medications are prescription drugs that can reduce core symptoms of ADHD — inattention, hyperactivity and impulsivity — and help people function at school, work and home.
What they’re used for
These medications are primarily used to treat ADHD in children, adolescents and adults. Some are also approved for other conditions, such as narcolepsy.
How they work
- Stimulants increase the availability of dopamine and norepinephrine in the brain, which can improve attention and self-control. They include methylphenidate-based and amphetamine-based medications, in short- and long-acting forms.
- Non-stimulants work in other ways. Atomoxetine and viloxazine affect norepinephrine. Guanfacine and clonidine (extended-release) act on receptors involved in attention and impulse control.
How they’re taken
Most ADHD medications are taken by mouth, often once or twice daily. Long-acting formulations are designed to last through the day. Prescribers typically adjust doses gradually and review benefits and side effects regularly. This page does not provide dosing guidance.
Common side effects
- Reduced appetite
- Difficulty sleeping
- Headache or stomachache
- Irritability or mood changes as medication wears off
- Increased heart rate and blood pressure (stimulants)
- Drowsiness or low blood pressure (guanfacine and clonidine)
Serious side effects
Contact a healthcare professional promptly about:
- Chest pain, fainting or shortness of breath
- New or worsening psychiatric symptoms, such as agitation, paranoia or hallucinations
- Circulation problems in the fingers or toes
- Thoughts of suicide (particularly with atomoxetine or viloxazine in young people)
Warnings
- Misuse: stimulants have a high potential for misuse. Store them securely and never share them.
- Heart health: tell your prescriber about any heart conditions or family history of sudden cardiac death.
- Growth: children’s height and weight are usually monitored.
- Stopping: guanfacine and clonidine should not be stopped suddenly because blood pressure can rebound.
Interactions
ADHD medications can interact with MAOIs (a dangerous combination), some antidepressants, blood pressure medications, and decongestants. Alcohol and other substances can increase risks. Tell your prescriber and pharmacist about everything you take.
Stimulants and non-stimulants compared
Stimulants, such as methylphenidate and amphetamine-based medicines, are the most widely used and have the largest evidence base for reducing core ADHD symptoms. They tend to work quickly, often within a day or so of starting or changing, and come in short-acting and longer-acting forms. They are controlled substances, so prescriptions are tightly regulated and usually require regular follow-up.
Non-stimulants, such as atomoxetine, viloxazine and guanfacine, are not controlled substances. They may be considered when stimulants aren’t suitable, aren’t effective enough, cause troublesome side effects or when there are concerns about misuse. They generally take longer to work, sometimes several weeks, and the effect is often more gradual. Atomoxetine and viloxazine carry a boxed warning about increased risk of suicidal thoughts in children and adolescents.
Choosing and adjusting treatment
There is no single best ADHD medicine. Prescribers consider age, symptoms, other health conditions, other medicines, how long you need coverage during the day, family and personal history of heart problems, substance use and your preferences. Finding the right medicine and schedule often involves trial and adjustment over weeks to months, with feedback from you (and, for children, from parents and teachers). Be open about what you notice, including benefits, side effects and how you feel when the medicine wears off.
Monitoring
Regular check-ups usually include asking about symptoms and side effects, checking blood pressure and heart rate, and tracking weight and, in children, height. Sleep, appetite and mood changes are common topics. Tell your prescriber about palpitations, chest pain, fainting or unusual mood changes, and seek urgent care for serious symptoms.
Medication is one part of treatment
Medication can reduce symptoms but doesn’t teach skills. Many people benefit from combining it with CBT adapted for ADHD, coaching, organizational strategies and adjustments at work or school. Taking care of sleep, movement and meals supports attention too. For adults, see ADHD in adults, and for the condition overview, see ADHD.
Safe storage and misuse
Because stimulants can be misused, store them securely, never share them and take them only as prescribed. Using stimulants without a prescription, or at amounts and in ways not directed, carries risks including heart problems, anxiety, sleep loss and dependence. If you notice cravings, taking more than prescribed or others pressuring you for your medicine, speak to your prescriber.
Getting care online
Rules for prescribing controlled substances through telehealth are strict and have changed over time. Some online services don’t prescribe stimulants at all, while those that do must follow legal requirements and good clinical practice. Check the prescribing policy before you book, and be cautious of services that promise a particular medicine or a diagnosis after a brief questionnaire. See finding ADHD care and our guide to online ADHD treatment.
Questions to ask your healthcare professional
- Would a stimulant or non-stimulant be more suitable for me, and why?
- What side effects should I watch for?
- How will we monitor heart rate, blood pressure or growth?
- How will we decide whether the dose is right?
- What non-medication strategies should I combine with treatment?
If you are considering online care, check what a service can prescribe. For example, Sesame prescribes non-stimulant ADHD medications such as atomoxetine and guanfacine but does not prescribe stimulants.
Related medication classes
Find care
Find the right support
Compare types of care — from online therapy to psychiatry — and learn what to consider before choosing a provider.
Explore care optionsWhen to seek professional help
Consider talking with a doctor or licensed mental health professional if symptomslast for more than two weeks, keep coming back, or make it harder to manage work, school, relationships or daily tasks. You don’t need to wait until things feel severe — getting support early often makes things easier.
If you’re thinking about harming yourself or are in immediate danger, call your local emergency number. In the US, call or text 988 (Suicide & Crisis Lifeline).Crisis resources in other countries.
Explore care optionsFrequently asked questions
Are ADHD medications safe for adults?
What is the difference between stimulants and non-stimulants?
Can I share my ADHD medication?
References
We rely on government health agencies, professional medical organizations, peer-reviewed research and academic institutions. Read our sourcing standards.
About this article
Written by
ExploreMentalHealth Editorial Team
Our editors research and write every article using government health agencies, professional medical organizations and peer-reviewed research, following our published editorial standards.
- First published
- September 10, 2026
- Last updated
- September 22, 2026
- Last medically reviewed
- Review pending